Morpholino pyrimidine derivatives and their use in therapy

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/42 (2006.01) C07D 401/04 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 405/04 (2006.01) C07D 405/10 (2006.01) C07D 405/14 (2006.01) C07D 407/14 (2006.01) C07D 409/04 (2006.01) C07D 413/10 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2635997

A compound of formula (I) or a salt, ester or prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of proliferative disease such as cancer and particularly in disease mediated by an mTOR kinase and/or one or more PI3K enzyme.

L'invention concerne un composé de formule (I) ou un sel, ester ou promédicament de celui-ci, des procédés pour les préparer, des compositions pharmaceutiques les contenant, ainsi que leur utilisation thérapeutique, par exemple dans le traitement d'une maladie proliférative telle que le cancer et en particulier une maladie médiée par une mTOR kinase et/ou par une ou plusieurs enzymes PI3K.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Morpholino pyrimidine derivatives and their use in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Morpholino pyrimidine derivatives and their use in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholino pyrimidine derivatives and their use in therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1383891

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.